Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 | Sep-30-20 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues |
| Research & Development Solutions | 7,681.0 | 7,622.0 | 7,556.0 | 7,296.0 | 6,843.0 | 6,187.0 | 5,760.0 | 5,547.0 |
| Technology & Analytics Solutions | 5,680.0 | 5,625.0 | 5,534.0 | 5,463.0 | 5,333.0 | 5,089.0 | 4,858.0 | 4,647.0 |
| Contract Sales & Medical Solutions | 775.0 | 786.0 | 784.0 | 777.0 | 755.0 | 738.0 | 741.0 | 762.0 |
| |
| EBITDA |
| |
| EBIT |
| |
| Mix |
| Research & Development Solutions | 54.3% | 54.3% | 54.5% | 53.9% | 52.9% | 51.5% | 50.7% | 50.6% |
| Technology & Analytics Solutions | 40.2% | 40.1% | 39.9% | 40.4% | 41.2% | 42.4% | 42.8% | 42.4% |
| Contract Sales & Medical Solutions | 5.5% | 5.6% | 5.7% | 5.7% | 5.8% | 6.1% | 6.5% | 7.0% |
| |
| Growth |
| Research & Development Solutions | 12.2% | 23.2% | 31.2% | 31.5% | 21.9% | 6.4% | -0.5% | -2.4% |
| Technology & Analytics Solutions | 6.5% | 10.5% | 13.9% | 17.6% | 17.6% | 12.4% | 8.3% | 5.6% |
| Contract Sales & Medical Solutions | 2.6% | 6.5% | 5.8% | 2.0% | -4.6% | -9.7% | -9.0% | -4.4% |
|